A specialized inpatient sickle cell disease (SCD) consult service led to improved pain management, shorter hospital stays and expanded use of individualized pain plans for patients with SCD.
Shaina M. Willen, MD, pediatric hematologist at the Vanderbilt University Medical Center, discusses the recent FDA approval of L-glutamine oral powder for sickle cell disease - the first FDA-approved...
Shaina M. Willen, MD, pediatric hematologist at the Vanderbilt University Medical Center, discusses the recent FDA approval of L-glutamine oral powder for sickle cell disease - the first FDA-approved...
Researchers investigated the impact of pre-transplant liver fibrosis on outcomes in patients with sickle cell disease undergoing hematopoietic stem cell transplantation.
A nationwide analysis reveals that patients with sickle cell disease (SCD) hospitalized for opioid overdose have comparable in-hospital mortality rates to patients without SCD, but exhibit better discharge...
